Conditions: 96.4% · VendorInvestigate · 99.4%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know…
coa
Page 17 of 32 · 749 questions tagged coa.
This is a first order from this supplier, so I have no track record to reason from. Everything I have found on this is either a forum aside or a product page, neither…
The case in front of me: 97.1% · VendorInvestigate · 96.4%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want…
Conditions: a quantified content assay · oral semaglutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and…
The case in front of me: chromatogram · SSA. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
This is my second independent submission on material from the same supplier. I would like to define my thresholds before I have a result, for obvious reasons. I want…
The pharmacy is accredited and I have verified that on the accreditor register. This is one of those things that everyone repeats and nobody derives. This matters…
What I have: KP · dulaglutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am interested in a…
For reference: 97.6% · list of related substances. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
I would rather spend on verification than on volume. I have done this once and I suspect I got away with it rather than got it right. For context: I keep records of…
Stated plainly: dulaglutide · two weeks · minus 80 °C. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…
What I am working with: 97.1% · Medutest · 97.9%. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not discarded…
Conditions: 97.9% · method section. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Stated plainly: QSC · mazdutide. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all citing each other.…
The case in front of me: TFC · Wuhan Wansheng Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option…
The method section is present, which is unusual enough that I want to make use of it. I would like help reading this properly rather than being told what conclusion…
For reference: QYB · Qingdao Saber Technology. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising for…
The specifics, since they change the answer: tirzepatide · ten weeks · 4 °C. I would like to define my thresholds before I have a result, for obvious reasons. I want…
Setup, so nobody has to ask: WXT · Xi’an Mokemei Biotechnology. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I…
What I am working with: retatrutide · eight weeks · 2–8 °C. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…
I have started asking labs for "the system suitability data" and getting back either silence, a shrug, or a screenshot of six retention times. I clearly do not know…
Stated plainly: 96.8% · batch certificate. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I…
I have the plan documents and the written criteria, which took two calls to obtain. I understand the observation; what I do not understand is the mechanism behind it.…
This is my second independent submission on material from the same supplier. I would like to understand the steps well enough to explain them to someone else. I have…